Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Offspring of mothers with preeclampsia have elevated risk for stroke, heart disease
In a Scandinavian cohort, offspring born to mothers with preeclampsia had elevated risk for ischemic heart disease and stroke, researchers reported in JAMA Network Open.
Inebilizumab reduces B-cell subsets in neuromyelitis optica spectrum disorder attacks
Treatment with inebilizumab was associated with reduction in aquaporin-4 antibody titers and B cells for those with neuromyelitis optica spectrum disorder, according to an expert at ECTRIMS 2022.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: When should benztropine be prescribed for patients with movement disorders?
Neurocrine Biosciences Inc. recently presented data on comorbidities, polypharmacy and treatment patterns of patients prescribed benztropine who also were being treated with antipsychotic medications.
Osteopathic manipulation treatment 'very effective' for post-COVID-19 symptoms
Osteopathic manipulation treatment may be an effective treatment option for alleviating post-COVID symptoms, according to a speaker at the American Osteopathic Association’s OMED conference.
FDA accepts NDA for generalized myasthenia gravis treatment
The FDA has accepted a new drug application for zilucoplan, an investigational treatment for generalized myasthenia gravis in adults who are acetylcholine receptor antibody positive, UCB announced in a released statement.
Alzheimer's treatment fails to meet primary endpoints in phase 3 trial
Gantenerumab, a treatment for mild cognitive impairment due to Alzheimer’s disease, did not meet the primary endpoint of slowing cognitive decline in a phase 3 clinical trial, Genentech announced in a released statement.
Set appropriate expectations for Treasury Inflation Protected Securities
Treasury Inflation Protected Securities, aka TIPS, provide investors with a return that is indexed to inflation over the life of the bond. With the sharp increase in inflation that began in 2021, many investors who own TIPS expected to see gains as a result.
FDA accepts NDA for extended-release carbidopa/levodopa Parkinson’s treatment
The FDA has accepted a new drug application from Amneal Pharmaceuticals Inc. for IPX203, an oral formulation of carbidopa/levodopa extended-release capsules for treatment of Parkinson’s disease, the company announced in a press release.
Oral ENT-01 improves constipation in patients with Parkinson’s disease
Oral ENT-01 treatment was safe and associated with improvements in constipation among patients with Parkinson’s disease, a study in Annals of Internal Medicine found.
AI-powered detection tool found 85% of aneurysms were not referred for follow-up
Viz.ai has announced that 85% of aneurysms detected by Viz Aneurysm, its artificial intelligence-based detection tool, previously had not been referred for neurovascular review.
-
Headline News
CDC warns of potential overdose risk from online pharmacy prescriptions
October 03, 20242 min read -
Headline News
AAP advocates against school suspensions, expulsions
October 03, 20243 min read -
Headline News
Study: No clear association between pet ownership and brain, heart health
October 03, 20241 min read
-
Headline News
CDC warns of potential overdose risk from online pharmacy prescriptions
October 03, 20242 min read -
Headline News
AAP advocates against school suspensions, expulsions
October 03, 20243 min read -
Headline News
Study: No clear association between pet ownership and brain, heart health
October 03, 20241 min read